Gerresheimer at CphI Worldwide 2021: Innovative SensAIR platform for a drug delivery device for biologics
With SensAIR, Gerresheimer presents an innovative platform for on-body drug delivery which can deliver drugs of higher viscosity, such as monoclonal antibodies (mAb). The aim is to provide patients with the best possible support in the subcutaneous delivery of large-volume Mehr



